Published in Lancet on July 24, 1982
Regulation and function of selenoproteins in human disease. Biochem J (2009) 1.93
Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. BMJ (1991) 1.64
Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr (2006) 1.62
Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med (2009) 1.21
Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J Epidemiol Community Health (1983) 1.21
Selenium and vitamin E in relation to risk factors for coronary heart disease. J Clin Pathol (1984) 1.15
Identification of a novel selenium-containing compound, selenoneine, as the predominant chemical form of organic selenium in the blood of bluefin tuna. J Biol Chem (2010) 1.11
Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest (1995) 1.11
Reduced selenium in asthmatic subjects in New Zealand. Thorax (1990) 1.09
Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey, 2003-2004. Am J Epidemiol (2009) 1.03
High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J Clin Biochem Nutr (2010) 1.03
The two faces of selenium-deficiency and toxicity--are similar in animals and man. Can J Vet Res (1986) 1.02
Mortality and cancer incidence in chloralkali workers exposed to inorganic mercury. Br J Ind Med (1990) 0.98
Serum concentration of selenium in healthy individuals living in Tehran. Nutr J (2005) 0.92
Discovery of the strong antioxidant selenoneine in tuna and selenium redox metabolism. World J Biol Chem (2010) 0.89
Mercury Exposure and Heart Diseases. Int J Environ Res Public Health (2017) 0.89
Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J (2008) 0.88
Longitudinal association between toenail selenium levels and measures of subclinical atherosclerosis: the CARDIA trace element study. Atherosclerosis (2010) 0.88
Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids. Br Med J (Clin Res Ed) (1983) 0.86
Factors associated with longitudinal plasma selenium decline in the elderly: the EVA study. J Nutr Biochem (2006) 0.85
Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study. Atherosclerosis (2009) 0.85
The impact of cardiopulmonary bypass on selenium status, thyroid function, and oxidative defense in children. Pediatr Cardiol (2004) 0.85
Selenium status and blood lipids: the cardiovascular risk in Young Finns study. J Intern Med (2011) 0.84
Selenistasis: epistatic effects of selenium on cardiovascular phenotype. Nutrients (2013) 0.84
Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study. Nutr Metab (Lond) (2010) 0.83
Relatively high mortality risk in elderly Swedish subjects with low selenium status. Eur J Clin Nutr (2015) 0.82
Fish and coronary artery disease. Br Heart J (1987) 0.81
The Tromsø Heart Study: serum selenium and risk of myocardial infarction a nested case-control study. J Epidemiol Community Health (1987) 0.80
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial. PLoS One (2015) 0.77
Plasma selenium levels and nonalcoholic fatty liver disease in Chinese adults: a cross-sectional analysis. Sci Rep (2016) 0.77
Increased hair selenium concentration in hyperlipidemic patients. J Cell Mol Med (2013) 0.76
Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial. Trials (2014) 0.76
The association between selenium and lipid levels: a longitudinal study in rural elderly Chinese. Arch Gerontol Geriatr (2014) 0.75
Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial. PLoS One (2016) 0.75
Selenium status and cardiovascular diseases: meta-analysis of prospective observational studies and randomized controlled trials. Eur J Clin Nutr (2015) 0.75
Yeast as a model system to study metabolic impact of selenium compounds. Microb Cell (2015) 0.75
Selenium and cardiometabolic health: inconclusive yet intriguing evidence. Am J Med Sci (2013) 0.75
Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2012) 0.75
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med (1987) 13.50
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59
Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02
Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse. Soc Sci Med (1997) 5.79
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health (2002) 5.48
Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet (1983) 5.31
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation (1992) 4.96
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst (1998) 4.72
The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30
Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23
Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet (1997) 4.19
Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ (1994) 3.92
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol (2000) 3.78
Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75
Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet (1995) 3.03
Symptoms of chronic bronchitis and the risk of coronary disease. Lancet (1996) 3.03
Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control (1996) 3.01
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Theory and action for health promotion illustrations from the North Karelia Project. Am J Public Health (1982) 2.95
Socioeconomic conditions in childhood and ischaemic heart disease during middle age. BMJ (1990) 2.91
Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol (1994) 2.91
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA (1988) 2.89
Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80
Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation (1999) 2.78
Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project. Am J Epidemiol (1981) 2.72
Community-based noncommunicable disease interventions: lessons from developed countries for developing ones. Bull World Health Organ (2001) 2.68
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet (2002) 2.65
The North Karelia project: an attempt at community prevention of cardiovascular disease. WHO Chron (1973) 2.53
Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol (1988) 2.53
Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med (1996) 2.49
Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J (2002) 2.46
Beer binging and mortality: results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study. BMJ (1997) 2.40
Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. Circulation (1999) 2.29
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (1995) 2.25
Decline in cardiovascular mortality in North Karelia and other parts of Finland. Br Med J (Clin Res Ed) (1986) 2.22
Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. Am J Epidemiol (1982) 2.20
Social connections and mortality from all causes and from cardiovascular disease: prospective evidence from eastern Finland. Am J Epidemiol (1988) 2.20
Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med (1995) 2.15
Association between body iron stores and the risk of acute myocardial infarction in men. Circulation (1998) 2.10
Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med (1994) 2.09
Socioeconomic status and ischemic stroke: The FINMONICA Stroke Register. Stroke (2001) 2.06
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
Changes in morbidity and mortality during comprehensive community programme to control cardiovascular diseases during 1972-7 in North Karelia. Br Med J (1979) 2.05
Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation (1996) 2.02
Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr (1991) 2.01
Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed) (1988) 1.90
Hostility and increased risk of mortality and acute myocardial infarction: the mediating role of behavioral risk factors. Am J Epidemiol (1997) 1.89
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia (2004) 1.85
Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol (1985) 1.84
Incidence and presentation of myocardial infarction in North Karelia, Finland. Acta Med Scand (1975) 1.84
Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol (1997) 1.84
Childhood socioeconomic position and cognitive function in adulthood. Int J Epidemiol (2001) 1.84
Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care (1997) 1.80
Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation (2000) 1.79
Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation (2000) 1.76
Psychology in action. Mass communication and community organization for public health education. Am Psychol (1980) 1.75
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75
Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care (1992) 1.75
Stopping smoking and long-term mortality after acute myocardial infarction. Br Heart J (1980) 1.74
Ten years of the North Karelia Project: results with community-based prevention of coronary heart disease. Scand J Soc Med (1983) 1.71
Nightmares as predictors of suicide. Sleep (2001) 1.71
Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol (2001) 1.70
Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Am J Public Health (2001) 1.69
Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status. Am J Clin Nutr (1991) 1.69
Long-term cost and life-expectancy consequences of hypertension. J Hypertens (1998) 1.68
Occasional smoking increases total and cardiovascular mortality among men. Nicotine Tob Res (2000) 1.67
Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation (1995) 1.67
Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. JAMA (1985) 1.66
The Finnish evidence-based guideline for open-angle glaucoma. Acta Ophthalmol Scand (2003) 1.66
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66
Rethinking the terms non-communicable disease and chronic disease. J Epidemiol Community Health (2003) 1.64
Socioeconomic status and risk of cancer, cerebral stroke, and death due to coronary heart disease and any disease: a longitudinal study in eastern Finland. J Epidemiol Community Health (1982) 1.64
Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ (1997) 1.61
Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med (1991) 1.60
Self rated health and mortality: a long term prospective study in eastern Finland. J Epidemiol Community Health (2001) 1.60
Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health (2001) 1.57
Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects. Eur J Clin Nutr (2010) 1.54
Reproducibility and validity of dietary assessment instruments. II. A qualitative food frequency questionnaire. Am J Epidemiol (1988) 1.53
Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet (2000) 1.53
Anger expression and incident stroke: prospective evidence from the Kuopio ischemic heart disease study. Stroke (1999) 1.53
Predictors of disability retirement. Scand J Work Environ Health (1997) 1.52
Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med (2002) 1.52
Life-style factors and risk for abdominal aortic aneurysm in a cohort of Finnish male smokers. Epidemiology (2001) 1.52
Does low socioeconomic status potentiate the effects of heightened cardiovascular responses to stress on the progression of carotid atherosclerosis? Am J Public Health (1998) 1.51